Products
  1. Home
  2. Products
  3. Inhibitors & Activators for IBD Research
Products
Inquiry

* Please note that all of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Panaxadiol

Cat. No.: IBDI-431232

Panaxadiol (20(R)-Panaxadiol) is an orally active HIF-1α/STAT3 inhibitor. Panaxadiol can suppress HIF-1α and STAT3 then lead to downregulation of programmed cell death-ligand 1 (PD-L1) expression. Panaxadiol shows anticancer, cardioprotective, anti-arrhythmic, and antioxidative activities.

Size (Solution): 10 mM * 1 mL in DMSO

Size (Solid + Solvent): 10 mM * 1 mL ready for reconstitution

Size (Solid):

Product Details

Target PD-1/PD-L1 | HIF/HIF Prolyl-Hydroxylase | STAT
Molecular Weight 460.73
Appearance Solid
Synonyms 20(R)-Panaxadiol
SMILES C[[email protected]@]1(CC[[email protected]@H]2O)[[email protected]](C[[email protected]]3O)([H])[[email protected]](CC[[email protected]@]1([H])C2(C)C)(C)[[email protected]@]4(C)[[email protected]@]3([H])[[email protected]]([[email protected]](CCC5)(C)OC5(C)C)([H])CC4
Structure Classification Terpenoids>Triterpenes
Purity ≥98.0%

Storage & Handling

Shipping Room temperature in continental US. May vary elsewhere.
Storage Powder: -20°C/3 years; 4°C/2 years
In solvent: -80°C/6 months; -20°C/1 month
Regulatory Status This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.
! For research use only, not intended for any clinical use.
Copyright © Ace Therapeutics. All rights reserved.